Apyx Medical

Apyx Medical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apyx Medical (APYX) as of Nov 1, 2026 is -6.45 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -19.01 M USD — a change of -66.08% (higher).

EBITDA

-6.45 MUSD

YoY

-66.08%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apyx Medical is 2025 -6.45 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apyx Medical was 2024 -19.01 M USD. It decreases by -66.08% higher compared to the previous year.

The Apyx Medical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-13.60 M USD
Jan 1, 2019
-20.87 M USD
Jan 1, 2020
-20.08 M USD
Jan 1, 2021
-14.45 M USD
Jan 1, 2022
-23.56 M USD
Jan 1, 2023
-20.46 M USD
Jan 1, 2024
-19.01 M USD
Jan 1, 2025
-6.45 M USD
The Apyx Medical EBITDA history
YEAREBITDAYoY
-6.45 MUSD-66.08%
-19.01 MUSD-7.10%
-20.46 MUSD-13.17%
-23.56 MUSD+63.08%
-14.45 MUSD-28.06%
-20.08 MUSD-3.77%
-20.87 MUSD+53.45%
-13.60 MUSD+163.31%
-5.17 MUSD+39.90%
-3.69 MUSD-47.15%
-6.99 MUSD+19.44%
-5.85 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apyx Medical Stock analysis

What does Apyx Medical do? Apyx Medical Corp is a US-American company specializing in the development and manufacturing of medical devices for medical aesthetics. The company is headquartered in Clearwater, Florida and has been listed on the Nasdaq stock exchange since 1997. However, the company was founded much earlier, in 1986, under the name Bovie Medical Corporation. Apyx Medical Corp's business model is focused on helping doctors and other medical professionals achieve better results for their patients. The company offers a wide range of medical aesthetic devices, which are divided into two main categories: devices for electrosurgery and devices for laser surgery. Electrosurgical devices use high frequencies to cut and coagulate tissue. These devices are primarily used for the removal of skin lesions, skin tightening, and the removal of wrinkles and excess tissue. Laser surgical devices, on the other hand, use laser beams to treat various skin problems, including the removal of wrinkles, pigmentation spots, and scars. Over the years, Apyx Medical Corp has become one of the leading companies in the field of medical aesthetics. The company is able to offer its customers a wide range of high-quality products that meet the highest standards of quality. The products of Apyx Medical Corp are used by medical professionals all over the world. The company also has a strong presence in the field of training and education for medical professionals. Apyx Medical Corp offers training and courses to ensure that doctors and other medical professionals can learn and apply the latest techniques and procedures in medical aesthetics. Apyx Medical Corp's products also include the J-Plasma and Renuvion systems. The Renuvion system is an advancement of the J-Plasma system and uses a high-frequency plasma arc to cut and coagulate tissue. The Renuvion system has a wide range of applications, ranging from fat removal to skin tightening. In recent years, Apyx Medical Corp has received a number of awards and recognitions. In 2019, the company was named one of America's best small companies by Forbes magazine. The company has also been included in Inc. Magazine's list of the 5000 fastest-growing companies. In the future, Apyx Medical Corp plans to further expand its product portfolio and strengthen its presence in the global market. The company is committed to providing its customers with the best products, training, and education in medical aesthetics and to remain a leading company in this field. In conclusion, Apyx Medical Corp is a leading company in the field of medical aesthetics, specializing in the development and manufacturing of medical devices. The company offers a wide range of high-quality products and training, and has become one of America's best small companies in recent years. Apyx Medical Corp has a promising future and is committed to providing its customers with the best products and services in the global market. Apyx Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apyx Medical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apyx Medical is -6.45 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Apyx Medical changed from -19.01 M USD to -6.45 M USD, representing a -66.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Apyx Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Apyx Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Apyx Medical

All Key Metrics — Apyx Medical